Growth inhibition of human MDA-MB-231 breast cancer cells by δ-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2641-2647

  Elangovan, Selvakumar ^a   Hsieh, Tze Chen ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

tTocotrienol; Breast cancer; Cell cycle; Cyclin D1; MDA MB 231 cells; Retinoblastoma

Indexed keywords

ALPHA TOCOTRIENOL; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; DELTA TOCOTRIENOL; ESTROGEN RECEPTOR; SERINE; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETINOBLASTOMA; TIME;

BREAST NEOPLASMS; CDC2 PROTEIN KINASE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYCLIN B; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; E2F TRANSCRIPTION FACTORS; HUMANS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; VITAMIN E;

EID: 55749115443     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Sporn MB and Suh N: Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2: 537-543, 2002.
3. Sen CK, Khanna S and Roy S: Tocotrienols: Vitamin E beyond tocopherols. Life Sci 78: 2088-2098, 2006.
4. McIntyre BS, Briski KP, Gapor A and Sylvester PW: Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224: 292-301, 2000.
5. McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A and Sylvester PW: Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35: 171-180, 2000.
6. Noguchi N, Hanyu R, Nonaka A, Okimoto Y and Kodama T: Inhibition of THP-1 cell adhesion to endothelial cells by alpha-tocopherol and alpha-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic Biol Med 34: 1614-1620, 2003.
7. Wali VB and Sylvester PW: Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells. Lipids 42: 1113-1123, 2007.
8. Agarwal MK, Agarwal ML, Athar M and Gupta S: Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3: 205-211, 2004.
9. Srivastava JK and Gupta S: Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 346: 447-453, 2006.
10. Sakai M, Okabe M, Tachibana H and Yamada K: Apoptosis induction by gamma-tocotrienol in human hepatoma Hep3B cells. J Nutr Biochem 17: 672-676, 2006.
11. Mo H and Elson CE: Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 229: 567-585, 2004.
12. Vaquero EC, Rickmann M and Molero X: Tocotrienols: balancing the mitochondrial crosstalk between apoptosis and autophagy. Autophagy 3: 652-654, 2007.
13. Mo H and Elson CE: Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutr 129: 804-813, 1999.
14. Miyazawa T, Inokuchi H, Hirokane H, Tsuzuki T, Nakagawa K and Igarashi M: Anti-angiogenic potential of tocotrienol in vitro. Biochemistry (Mosc) 69: 67-69, 2004.
15. Nesaretnam K, Stephen R, Dils R and Darbre P: Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33: 461-469, 1998.
16. Yu W, Simmons-Menchaca M, Gapor A, Sanders BG and Kline K: Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 33: 26-32, 1999.
17. Shun MC, Yu W, Gapor A, Parsons R, Atkinson J, Sanders BG and Kline K: Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer 48: 95-105, 2004.
18. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL and Wu JM: Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 337: 224-231, 2005.
19. Zarkowska T and Mittnacht S: Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272: 12738-12746, 1997.
20. Shapiro GI: Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24: 1770-1783, 2006.
21. Stiegler P and Giordano A: The family of retinoblastoma proteins. Crit Rev Eukaryot Gene Expr 11: 59-76, 2001.
22. Masciullo V, Khalili K and Giordano A: The Rb family of cell cycle regulatory factors: clinical implications. Int J Oncol 17: 897-902, 2000.
23. Lees JA, Buchkovich KJ, Marshak DR, Anderson CW and Harlow E: The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. Embo J 10: 4279-4290, 1991.
24. Blagden S and de Bono J: Drugging cell cycle kinases in cancer therapy. Curr Drug Targets 6: 325-335, 2005.
25. Adams PD: Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta 1471: M123-133, 2001.
26. Giacinti C and Giordano A: RB and cell cycle progression. Oncogene 25: 5220-5227, 2006.